AI-Powered Drug Discovery & Development—Faster, Smarter, Affordable
About Encure Bio
Our History
Our Technology
Our Technology
Encure Biotherapeutics: Pioneering the Future of AI-Driven Biopharma
Founded in 2025, Encure Biotherapeutics was established with a bold vision—to revolutionize Bio-Pharma innovation through cutting-edge AI-driven drug discovery, formulation development, and clinical translation.
Our Technology
Our Technology
Our Technology
At Encure Biotherapeutics, we harness cutting-edge AI-driven and biopharmaceutical technologies alongside a team of renowned scientists to accelerate the development of breakthrough therapies. By integrating Generative AI, computational chemistry, and advanced formulation science, we are transforming drug discovery, optimizing drug deliv
At Encure Biotherapeutics, we harness cutting-edge AI-driven and biopharmaceutical technologies alongside a team of renowned scientists to accelerate the development of breakthrough therapies. By integrating Generative AI, computational chemistry, and advanced formulation science, we are transforming drug discovery, optimizing drug delivery, and enhancing clinical success rates—bringing next-generation treatments to patients faster and more efficiently.
Our Values
Our Technology
Our Values
At Encure Biotherapeutics, we are committed to ethical and responsible biotech innovation. Our mission is to put patients first by developing safe, effective, and accessible therapies. With a focus on scientific excellence, transparency, and innovation, we strive to advance breakthrough treatments that address unmet medical needs while upholding the highest standards of safety and efficacy.
Encure Biotherapeutics Transforming AI-Driven Biopharma
A Unified Team of AI & Biopharma Innovators
Encure Biotherapeutics brings together leading experts in biopharma, AI/ML, and computational drug development to create an end-to-end AI-powered platform.
Advanced AI-Powered Molecular Design & Drug Repurposing
- Our most advanced Generative AI models for small molecules, biologics, PROTACs, molecular glues, and RNA therapeutics.
- Predictive AI-driven molecular screening to accelerate both de novo drug design and drug repurposing.
Predictive Formulation & Advanced Drug Delivery
- AI-powered formulation development for lipid nanoparticles (LNPs), liposomes, nanostructured lipid carriers (NLCs), micelles, antibody-drug conjugates (ADCs), and polymeric nanoparticles.
- Long-acting injectables, implants, and amorphous drug delivery systems for controlled and sustained drug release.
- AI-driven oral drug delivery: Solid dosage forms (tablets, capsules), oral thin films, self-emulsifying drug delivery systems (SEDDS), and thermal stabilization of biologics.
- 3D-printed pharmaceuticals, integrating AI to optimize large-molecule drug delivery.
Clinical Trial Optimization, Preclinical Validation & Regulatory AI
- AI-driven preclinical prediction models to assess pharmacokinetics, toxicology, and efficacy, reducing late-stage failures.
- AI-enhanced clinical trials, including patient stratification, synthetic control arms, and adaptive trial designs.
- Regulatory intelligence & AI-driven risk assessment to streamline drug approval processes.
Our Mission
We are committed to transforming drug discovery and development by leveraging AI to:
- Accelerate new drug design through our most advanced AI models for molecular discovery and drug repurposing.
- Optimize formulations with predictive modeling for nanomedicine, long-acting delivery, and oral biologics.
- Enhance clinical success rates with AI-powered trial design and regulatory optimization.
- Reduce development costs and timelines, making innovative therapies accessible faster.
Why Encure?
Revolutionizing Drug Discovery & Development with AI
Encure bio differentiates itself by integrating AI across the entire pharmaceutical R&D lifecycle, from early-stage drug discovery to preclinical validation, clinical trial acceleration, and regulatory optimization.
- AI-Powered Molecular Design & Drug Repurposing – Leveraging our most advanced Generative AI platform for small molecules, biologics, PROTACs, molecular glues, and RNA therapeutics, supported by preclinical prediction models.
- Predictive Formulation & Advanced Drug Delivery – AI-driven formulation for lipid nanoparticles (LNPs), long-acting injectables, implants, oral biologics, amorphous drug delivery systems, and 3D-printed pharmaceuticals.
- Clinical Trial Optimization, Preclinical Validation & Regulatory AI – AI-enhanced preclinical prediction, patient stratification, synthetic control arms, and trial design to reduce costs and improve success rates.
- By bridging AI, preclinical validation, nanoformulation, and translational science, Encure bio is redefining how life-changing therapies are discovered, developed, and delivered—bringing novel medicines to patients faster, more efficiently, and with greater precision.